Breaking News Instant updates and real-time market news.

ACOR

Acorda Therapeutics

$27.80

0.9 (3.35%)

07:05
08/14/18
08/14
07:05
08/14/18
07:05

Acorda Therapeutics CTO Rick Batycky to depart

Acorda Therapeutics announced that Rick Batycky, CTO, will be leaving Acorda as of August 20, 2018 to take a position as the CEO of a private, venture-backed biotechnology company. David Lawrence, Acorda's chief of business operations, will assume responsibility for the company's Chelsea, MA manufacturing facility, which produces INBRIJA as well as for the external manufacturing of AMPYRA. Burkhard Blank, CMO, will assume responsibility for Acorda's Pharmaceutical Development and Technical Operations teams.

  • 05

    Oct

ACOR Acorda Therapeutics
$27.80

0.9 (3.35%)

02/15/18
PIPR
02/15/18
UPGRADE
PIPR
Overweight
Acorda Therapeutics upgraded to Overweight from Neutral at Piper Jaffray
02/16/18
PIPR
02/16/18
UPGRADE
Target $37
PIPR
Overweight
Piper upgrades Acorda to Overweight on potential in Parkinson's
Piper Jaffray analyst Charles Duncan last night upgraded Acorda Therapeutics and raised his price target for the shares to $37 from $32. The analyst, based on diligence in the Parkinson's space, has "enhanced conviction" that Inbrija can be a $700M-$800M drug in the U.S. alone. He sees a "risk-reduced regulatory path" ahead in the U.S. and Europe. Acorda closed yesterday down 50c to $25.10.
07/30/18
CANT
07/30/18
NO CHANGE
Target $17
CANT
Neutral
Acorda's last patent for Ampyra expires today, says Cantor Fitzgerald
Exclusivity for the last valid Ampyra patent expires today, Cantor Fitzgerald analyst William Tanner tells investors in a research note. The analyst points out that four other Orange Book-listed patents were ruled invalid by a District Court in 2017. Shares of Acorda Therapeutics are down 17% since the company disclosed on July 25 that a U.S. Court of Appeals denied a motion for an injunction pending its appeal of that decision, Tanner writes. He notes that exclusivity expiration of the last valid patent coupled with the injunction denial means that generic fampridine developers could launch their versions. The analyst reiterates a Neutral rating on Acorda with a $17 price target.
08/07/18
STFL
08/07/18
INITIATION
Target $25
STFL
Hold
Acorda Therapeutics resumed with a Hold at Stifel
Stifel analyst Paul Matteis resumed coverage of Acorda Therapeutics with a Hold rating and a $25 price target, stating that his long-term confidence in Inbrija is balanced by his expectation that the launch may ramp linearly and could lag 2019/2020 consensus expectations.

TODAY'S FREE FLY STORIES

JCOM

j2 Global

$70.35

1.09 (1.57%)

11:27
12/12/18
12/12
11:27
12/12/18
11:27
Hot Stocks
j2 Global mentioned cautiously in new GlassHouse Research short report »

GlassHouse Research has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 19

    Dec

LOW

Lowe's

$88.53

-0.96 (-1.07%)

11:27
12/12/18
12/12
11:27
12/12/18
11:27
Hot Stocks
Breaking Hot Stocks news story on Lowe's »

Lowe's trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 27

    Feb

11:25
12/12/18
12/12
11:25
12/12/18
11:25
Conference/Events
Stephens retail/hardlines analyst to hold luncheon meeting »

Retail Hardlines Analyst…

AVYA

Avaya

$17.78

0.305 (1.75%)

11:24
12/12/18
12/12
11:24
12/12/18
11:24
Hot Stocks
Avaya targets long-term non-GAAP revenue growth CAGR of 2%-4% »

Among other long-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

AVYA

Avaya

$17.78

0.305 (1.75%)

11:22
12/12/18
12/12
11:22
12/12/18
11:22
Earnings
Avaya sees FY19 non-GAAP revenue $3.05B-$3.15B, consensus $3.09B »

Sees FY19 non-GAAP gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

TME

Tencent Music

$0.00

(0.00%)

11:20
12/12/18
12/12
11:20
12/12/18
11:20
Syndicate
Breaking Syndicate news story on Tencent Music »

Tencent Music opens at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

AVYA

Avaya

$17.78

0.305 (1.75%)

11:18
12/12/18
12/12
11:18
12/12/18
11:18
Hot Stocks
Breaking Hot Stocks news story on Avaya »

Avaya Holdings trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
12/12/18
12/12
11:17
12/12/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
12/12/18
12/12
11:16
12/12/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPR

Tapestry

$36.28

1.31 (3.75%)

11:10
12/12/18
12/12
11:10
12/12/18
11:10
Options
Call buyers in Tapestry as shares advance from 52-week lows »

Call buyers in Tapestry…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACN

Accenture

$160.17

1.86 (1.17%)

11:07
12/12/18
12/12
11:07
12/12/18
11:07
Hot Stocks
Accenture to acquire digital media services company Adaptly »

Accenture announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Dec

11:05
12/12/18
12/12
11:05
12/12/18
11:05
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

JCOM

j2 Global

$71.15

1.89 (2.73%)

11:04
12/12/18
12/12
11:04
12/12/18
11:04
Periodicals
j2 Global mentioned cautiously in short report from GlassHouse Research »

GlassHouse Research…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 19

    Dec

PKD

Parker Drilling

$1.12

(0.00%)

11:04
12/12/18
12/12
11:04
12/12/18
11:04
Hot Stocks
Parker Drilling enters Chapter 11 under restructuring support agreement »

Parker Drilling Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$57.52

-1.33 (-2.26%)

, BAC

Bank of America

$24.57

-0.01 (-0.04%)

11:01
12/12/18
12/12
11:01
12/12/18
11:01
On The Fly
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's top…

VZ

Verizon

$57.52

-1.33 (-2.26%)

BAC

Bank of America

$24.57

-0.01 (-0.04%)

MS

Morgan Stanley

$41.00

0.38 (0.94%)

TSLA

Tesla

$368.00

1.37 (0.37%)

ROKU

Roku

$35.66

-0.16 (-0.45%)

CORT

Corcept Therapeutics

$18.72

1.56 (9.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

  • 14

    Dec

  • 18

    Dec

  • 19

    Dec

  • 12

    Feb

EFA

iShares MSCI EAFE Index Fund

$61.52

1.04 (1.72%)

11:00
12/12/18
12/12
11:00
12/12/18
11:00
Options
Million dollar straddle purchase in iShares EAFE International ETF »

Million dollar straddle…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHC

Bausch Health

$24.99

1.9 (8.23%)

, SGYP

Synergy Pharmaceuticals

$0.10

-0.2416 (-71.06%)

10:59
12/12/18
12/12
10:59
12/12/18
10:59
Recommendations
Bausch Health, Synergy Pharmaceuticals, Allergan analyst commentary  »

Synergy's GI assets…

BHC

Bausch Health

$24.99

1.9 (8.23%)

SGYP

Synergy Pharmaceuticals

$0.10

-0.2416 (-71.06%)

AGN

Allergan

$153.11

3.47 (2.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 25

    Feb

AVYA

Avaya

$17.70

0.225 (1.29%)

10:55
12/12/18
12/12
10:55
12/12/18
10:55
Hot Stocks
Breaking Hot Stocks news story on Avaya »

Avaya Holdings trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

ZAYO

Zayo Group

$25.42

0.185 (0.73%)

10:50
12/12/18
12/12
10:50
12/12/18
10:50
Options
Call buyers in Zayo and implied volatility spikes to 52-week highs »

Call buyers in Zayo and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TME

Tencent Music

$0.00

(0.00%)

10:49
12/12/18
12/12
10:49
12/12/18
10:49
Syndicate
Breaking Syndicate news story on Tencent Music »

Tencent Music indicated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

MS

Morgan Stanley

$41.30

0.68 (1.67%)

, BAC

Bank of America

$24.67

0.09 (0.37%)

10:47
12/12/18
12/12
10:47
12/12/18
10:47
On The Fly
KBW, Atlantic turn more bearish on big banks amid ‘subdued’ environment »

In a research note to…

MS

Morgan Stanley

$41.30

0.68 (1.67%)

BAC

Bank of America

$24.67

0.09 (0.37%)

GS

Goldman Sachs

$178.50

1.76 (1.00%)

KEY

KeyCorp

$16.07

0.145 (0.91%)

CMA

Comerica

$73.10

1.74 (2.44%)

CFG

Citizens Financial

$32.20

0.52 (1.64%)

MTB

M&T Bank

$154.49

0.94 (0.61%)

STI

SunTrust

$54.56

0.08 (0.15%)

ZION

Zions Bancorp

$44.03

0.6 (1.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 16

    Jan

  • 17

    Jan

  • 12

    Feb

AVEO

Aveo Pharmaceuticals

$2.01

-0.02 (-0.99%)

, AZN

AstraZeneca

$39.20

0.57 (1.48%)

10:45
12/12/18
12/12
10:45
12/12/18
10:45
Recommendations
Aveo Pharmaceuticals, AstraZeneca analyst commentary  »

Piper Jaffray reiterates…

AVEO

Aveo Pharmaceuticals

$2.01

-0.02 (-0.99%)

AZN

AstraZeneca

$39.20

0.57 (1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APD

Air Products

$156.93

0.975 (0.63%)

10:42
12/12/18
12/12
10:42
12/12/18
10:42
Hot Stocks
Air Products to build, operate large-scale air separation unit in Minnesota »

Air Products announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$66.46

0.56 (0.85%)

10:40
12/12/18
12/12
10:40
12/12/18
10:40
Options
Aggressive call buying in Starbucks weekly options ahead of a company event »

Aggressive call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

10:40
12/12/18
12/12
10:40
12/12/18
10:40
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.